Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of RAAS Blockade on Renal Outcome in CKD Stage 3-4 with Type 2 Diabetes Mellitus
TCTR20230512002Unknown
- Sponsor
- Faculty of Pharmaceutical Sciences, Burapha University
- Start
- Jul 2023
- Countries
- 1
01
Overview
Open-label trial in chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Faculty of Pharmaceutical Sciences, Burapha University. Primary endpoint: Renal outcome. Status: unknown.
02
Conditions
chronic kidney disease (CKD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20230512002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230512002.